Thailand Ministry of Public Health (MOPH)-U.S. Centers for Disease Control and Prevention Collaboration (TUC), Nonthaburi, Thailand.
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Am J Trop Med Hyg. 2019 Apr;100(4):943-951. doi: 10.4269/ajtmh.18-0394.
Bloodstream infection surveillance conducted from 2008 to 2014 in all 20 hospitals in Sa Kaeo and Nakhon Phanom provinces, Thailand, allowed us to look at disease burden, antibiotic susceptibilities, and recurrent infections caused by extended-spectrum β-lactamase (ESBL)-producing and . Of 97,832 blood specimens, 3,338 were positive for and 1,086 for . The proportion of isolates producing ESBL significantly increased from 19% to 22% in 2008-2010 to approximately 30% from 2011 to 2014 (-value for trend = 0.02), whereas ESBL production among cases was 27.4% with no significant trend over time. Incidence of community-onset ESBL-producing increased from 5.4 per 100,000 population in 2008 to 12.8 in 2014, with the highest rates among persons aged ≥ 70 years at 79 cases per 100,000 persons in 2014. From 2008 to 2014, community-onset ESBL-producing incidence was 2.7 per 100,000, with a rate of 12.9 among those aged ≥ 70 years. Although most (93.6% of and 87.6% of ) infections were community-onset, hospital-onset infections were twice as likely to be ESBL. Population-based surveillance, as described, is vital to accurately monitor emergence and trends in antimicrobial resistance, and in guiding the development of rational antimicrobial therapy recommendations.
2008 年至 2014 年,在泰国沙缴府和那空帕农府的 20 家医院进行了血流感染监测,使我们能够了解疾病负担、抗生素药敏性以及产超广谱β-内酰胺酶(ESBL)的 和 的复发性感染。在 97832 份血样中,有 3338 份为 和 1086 份为 阳性。2008-2010 年间,产 ESBL 的 分离株的比例从 19%显著增加到 22%,而 2011-2014 年间则约为 30%(趋势值=0.02),而 病例中 ESBL 的产生率为 27.4%,无明显时间趋势。社区获得性产 ESBL 的 发病率从 2008 年的每 10 万人 5.4 例上升到 2014 年的每 10 万人 12.8 例,其中 70 岁以上人群的发病率最高,为 2014 年每 10 万人 79 例。2008 年至 2014 年,社区获得性产 ESBL 的 发病率为每 10 万人 2.7 例,其中 70 岁以上人群的发病率为 12.9%。虽然大多数(93.6%的 和 87.6%的 )感染为社区获得性,但医院获得性感染发生 ESBL 的可能性是前者的两倍。如前所述,基于人群的监测对于准确监测抗菌药物耐药性的出现和趋势以及指导合理抗菌药物治疗建议的制定至关重要。